Cargando…

Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors()

Patient-derived xenograft (PDX) tumor models have emerged as a new approach to evaluate the effects of cancer drugs on patients’ personalized tumor grafts enabling to select the best treatment for the cancer patient and providing a new tool for oncology drug developers. Here, we report that human tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bondarenko, Gennadiy, Ugolkov, Andrey, Rohan, Stephen, Kulesza, Piotr, Dubrovskyi, Oleksii, Gursel, Demirkan, Mathews, Jeremy, O’Halloran, Thomas V., Wei, Jian J., Mazar, Andrew P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611072/ https://www.ncbi.nlm.nih.gov/pubmed/26476081 http://dx.doi.org/10.1016/j.neo.2015.09.004

Ejemplares similares

Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models()()
por: Ugolkov, Andrey, et al.
Publicado: (2017)

Identification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (αM)
por: Xu, Xiang, et al.
Publicado: (2014)

Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer
por: Ugolkov, Andrey V., et al.
Publicado: (2018)

The Many Spaces of uPAR: Delivery of Theranostic Agents and Nanobins to Multiple Tumor Compartments through a Single Target
por: O'Halloran, Thomas V., et al.
Publicado: (2013)

The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy
por: Talebian, Fatemeh, et al.
Publicado: (2012)

Modeling Tumor-Host Interactions of Chronic Lymphocytic Leukemia in Xenografted Mice to Study Tumor Biology and Evaluate Targeted Therapy
por: Herman, Sarah E. M., et al.
Publicado: (2013)

GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents
por: Karmali, Reem, et al.
Publicado: (2017)

Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft
por: Le, Duy Tri, et al.
Publicado: (2021)

Novel Phenotypic Fluorescent Three-Dimensional Co-Culture Platforms for Recapitulating Tumor in vivo Progression and for Personalized Therapy
por: Fang, Changge, et al.
Publicado: (2013)

Applications of patient-derived tumor xenograft models and tumor organoids
por: Yoshida, Go J.
Publicado: (2020)

Clinically relevant GSK-3β inhibitor 9-ING-41 is active as a single agent and in combination with other antitumor therapies in human renal cancer
por: Anraku, Tsutomu, et al.
Publicado: (2020)

Development of patient-derived tumor organoids and a drug testing model for renal cell carcinoma
por: Kazama, Akira, et al.
Publicado: (2021)

The Anti-Tumoral Potential of Phosphonate Analog of Sulforaphane in Zebrafish Xenograft Model
por: Rudzinska-Radecka, Magdalena, et al.
Publicado: (2021)

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer
por: Kuroki, Hiroo, et al.
Publicado: (2019)

Enhancement of Tumor Radio‐response by Irinotecan in Human Lung Tumor Xenografts
por: Tamura, Kenji, et al.
Publicado: (1997)

Modeling Lung Carcinoids with Zebrafish Tumor Xenograft
por: Carra, Silvia, et al.
Publicado: (2022)

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts()()
por: Butler, Kristina A., et al.
Publicado: (2017)

Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in Mice
por: Labitzky, Vera, et al.
Publicado: (2020)

Brain tumor patients and COVID-19 vaccines: results of an international survey
por: Voisin, Mathew R, et al.
Publicado: (2022)

Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials
por: Chateau-Joubert, Sophie, et al.
Publicado: (2021)

The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts
por: Fung, Andrea S, et al.
Publicado: (2015)

Primary Tumor Site Specificity is Preserved in Patient-Derived Tumor Xenograft Models
por: Chen, Lei, et al.
Publicado: (2019)

Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse
por: Rijensky, Nataly Mancette, et al.
Publicado: (2020)

Loci controlling lymphocyte production of interferon γ after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility
por: Lipoldová, Marie, et al.
Publicado: (2009)

Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts
por: Leiting, Jennifer L., et al.
Publicado: (2019)

Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors
por: Hillman, Gilda G., et al.
Publicado: (2014)

Orthotopic Patient-Derived Xenografts of Pediatric Solid Tumors
por: Stewart, Elizabeth, et al.
Publicado: (2017)

Targeted Imaging of Tumor-Associated Macrophages by Cyanine 7-Labeled Mannose in Xenograft Tumors
por: Jiang, Chong, et al.
Publicado: (2017)

PDX Finder: A portal for patient-derived tumor xenograft model discovery
por: Conte, Nathalie, et al.
Publicado: (2019)

Early Life Exposure to Chronic Intermittent Hypoxia Primes Increased Susceptibility to Hypoxia-Induced Weakness in Rat Sternohyoid Muscle during Adulthood
por: McDonald, Fiona B., et al.
Publicado: (2016)

Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
por: Bellone, Matteo, et al.
Publicado: (2013)

Protein Phosphatase 2A Mediates Dormancy of Glioblastoma Multiforme-Derived Tumor Stem-Like Cells during Hypoxia
por: Hofstetter, Christoph P., et al.
Publicado: (2012)

Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model
por: Kashima, Soki, et al.
Publicado: (2020)

Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
por: Stuckey, Ashley, et al.
Publicado: (2011)

Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts
por: Hadler-Olsen, Elin, et al.
Publicado: (2010)

Origin of the vasculature supporting growth of primary patient tumor xenografts
por: Hylander, Bonnie L, et al.
Publicado: (2013)

Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx)
por: Chaudary, Naz, et al.
Publicado: (2012)

Dynamic Quantitative T1 Mapping in Orthotopic Brain Tumor Xenografts()
por: Herrmann, Kelsey, et al.
Publicado: (2016)

Assessment of Hypoxia in the Stroma of Patient-Derived Pancreatic Tumor Xenografts
por: Lohse, Ines, et al.
Publicado: (2014)

Tumor xenograft animal models for esophageal squamous cell carcinoma
por: Lee, Nikki P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8s6miosaeg821422vr8d0uh06q